CCM
CELG

CrestPoint Capital Management’s Celgene Corp CELG Stock Holding History

CrestPoint Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$532K Hold
5,100
– – 0.3% 113
2017
Q3 		$744K Buy
5,100
+1,900
+59% +$259K 0.33% 106
2017
Q2 		$416K Sell
3,200
-100
-3% -$12.3K 0.2% 159
2017
Q1 		$411K Sell
3,300
-200
-6% -$23.9K 0.2% 154
2016
Q4 		$405K Buy
+3,500
New +$390K 0.2% 156
2016
Q3 		– Sell
-2,500
Closed -$247K – 250
2016
Q2 		$247K Hold
2,500
– – 0.13% 184
2016
Q1 		$250K Sell
2,500
-300
-11% -$30.9K 0.14% 181
2015
Q4 		$335K Buy
+2,800
New +$324K 0.19% 140
2015
Q2 		– Sell
-2,200
Closed -$254K – 226
2015
Q1 		$254K Hold
2,200
– – 0.13% 199
2014
Q4 		$246K Buy
+2,200
New +$232K 0.13% 204

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CrestPoint Capital Management's CELG Position: Q4 2017 in Review

CrestPoint Capital Management held its Celgene Corp (CELG) position steady in Q4 2017 at 5,100 shares worth $532K. The position accounts for 0.3% of the portfolio, ranked #113.

CrestPoint Capital Management first reported a position in CELG in Q4 2014 and has held it in 10 quarters since. The position peaked at $744K in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • CrestPoint Capital Management held 5,100 shares of Celgene Corp worth $532K as of Q4 2017.
  • CrestPoint Capital Management left its Celgene Corp share count unchanged in Q4 2017.
  • Celgene Corp made up 0.3% of CrestPoint Capital Management's portfolio in Q4 2017, its #113 holding.
  • CrestPoint Capital Management first reported a position in Celgene Corp in Q4 2014 and has held it in 10 quarters since.
  • CrestPoint Capital Management's Celgene Corp position peaked at $744K in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.